DJIA 17,098.45 0.00 0.00%
NASDAQ 4,580.27 0.00 0.00%
S&P 500 2,003.37 0.00 0.00%
market minute promo

Gilead Sciences (NASDAQ: GILD)

107.56 0.00 (0.00%)

REAL-TIME: Last trade at


company name or ticker

Recent Quotes

GILD $107.56 0.00%
Company Photos
(Click to zoom)
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $107.90
Previous Close $107.56
Daily Range $106.78 - $108.24
52-Week Range $58.81 - $108.77
Market Cap $162.6B
P/E Ratio 24.23
Dividend (Yield) $0.00 (0.0%)
Volume 11,324,215
Average Daily Volume 13,437,229
Current FY EPS $7.26

Sector

Healthcare

Industry

Drugs

Gilead Sciences (GILD) Description

Gilead Sciences created and sells the world’s top-selling HIV medications, Truvada and Atripla, and commands about 75% of the U.S. treatment market and more than 50% worldwide. Website: http://www.gilead.com/

News & Commentary Rss Feed

3 Simple Ways to Invest Like George Soros

George Soros is one of the most successful investors of all time. Here are three easy ways to follow in his footsteps.

Mike Khouw's Gilead Sciences Trade

Regeneron Pharmaceuticals' Pipeline Progress Raises Costs - Analyst Blog

Regeneron Pharmaceuticals' Pipeline Progress Raises Costs - Analyst Blog

Pfizer's C. Difficile Vaccine Gets Fast Track Status - Analyst Blog

What You Need to Know About the Roche-InterMune Deal

Market Posts Best August In 14 Years. Why Don't Investors Feel Better?

Today's Market: Red Hot Biotech And Big Pharma Names To Watch

Bristol-Myers' Oral HCV Treatment Daklinza Gets EU Clearance - Analyst Blog

RedHill Expands ERADICATE Study on RHB-105 for H. pylori - Analyst Blog

RedHill Expands ERADICATE Study on RHB-105 for H. pylori - Analyst Blog

Has Gilead Sciences, Inc.'s Star Drug Already Peaked?

Prescriptions of Gilead Sciences' hepatitis C drug Sovaldi peaked, but sales will pick up after the new combination product is approved.

See More GILD News...

GILD's Top Competitors

GILD $107.56 (0.00%)
Current stock: GILD
AMGN $139.23 (-0.11%)
Current stock: AMGN
CELG $95.02 (0.00%)
Current stock: CELG
$0.00 (0.00%)
Current stock: